4-[(2,6-dichlorobenzyl)oxy]-3-ethoxybenzaldehyde, 250mg

N-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 98%, 100mg

2,4,6-Tribromophenyl acrylate, 95.0%, 25g

Spiro[3.4]octan-2-one, 98%, 500mg

1-(4-Chlorobenzoyl)piperidin-4-one, 95+%, 500mg

(R)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl acetate, 97% mix TBC as stabilizer, 1g

(4S,4'S)-4,4'-Di((S)-sec-butyl)-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

4-(4-methoxyphenoxy)benzoic acid, 95.0%, 10g

(2,3-Dihydrobenzofuran-6-yl)methanamine, 98+%, 1g

1,3-Dimethyl-1H-imidazol-3-ium Tetrafluoroborate>97.0%(T)25g

1-Ethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 10g

2-CHLORO-5-IODOBENZYL BROMIDE, 95.0%, 2g

2-(2-Aminobenzoyl)benzoic acid, 95.0%, 25g